Managed Healthcare

Search documents
Why Centene Stock Dropped 40% — And Whether It's a Buy Now
MarketBeat· 2025-07-08 11:02
Centene TodayCNCCentene$33.06 -0.25 (-0.75%) 52-Week Range$32.99▼$80.59P/E Ratio4.93Price Target$68.87Add to WatchlistFor healthcare stock Centene NYSE: CNC, July 2 was indisputably disastrous. Shares closed down by over 40% that day, resulting in the firm losing over $11 billion in market capitalization. Close competitors were not spared either. Molina Healthcare NYSE: MOH dropped 22%, and Elevance Health NYSE: ELV fell over 11%.Get Centene alerts:So, what caused Centene to see one of the largest single-d ...
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Centene Corporation (NYSE: CNC) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-07-08 02:56
Core Viewpoint - Centene Corporation is under investigation for potential violations of federal securities laws due to allegations of providing misleading business information, which has led to significant stock price decline following the withdrawal of its earnings guidance [1][4]. Company Overview - Centene is a managed healthcare company that specializes in government-sponsored programs such as Medicaid and Medicare, as well as health insurance plans on individual exchanges and commercial marketplaces [3]. Alleged Wrongdoing - On July 1, 2025, Centene announced its decision to withdraw its 2025 earnings guidance, citing declining market growth in 22 out of the 29 states it operates in. The company indicated that health risks in these states were much higher than previously anticipated in its risk adjustment calculations [4]. - Following this announcement, Centene's stock price dropped by $22.87 per share, representing a 40.37% decline, closing at $33.78 per share on July 2, 2025 [4].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Centene Corporation - CNC
Prnewswire· 2025-07-07 19:58
NEW YORK, July 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Centene Corporation ("Centene" or the "Company") (NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Centene and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On July 1, 2025, Centene ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Centene Corporation - CNC
GlobeNewswire News Room· 2025-07-06 14:00
Core Viewpoint - Centene Corporation is facing an investigation regarding potential securities fraud and unlawful business practices following its withdrawal of earnings guidance due to disappointing market growth and higher-than-expected health risks [1][3]. Group 1: Company Performance - On July 1, 2025, Centene announced the withdrawal of its 2025 GAAP and adjusted diluted earnings per share (EPS) guidance, citing that market growth in 22 out of 29 states was not meeting expectations [3]. - The company indicated that the overall health risks in these states were significantly higher than anticipated, impacting its risk adjustment revenue calculations [3]. Group 2: Market Reaction - Following the announcement, Centene's stock price experienced a significant decline, falling by $22.87 per share, or 40.37%, closing at $33.78 per share on July 2, 2025 [4]. Group 3: Legal Investigation - Pomerantz LLP is investigating claims on behalf of Centene investors regarding possible securities fraud or other unlawful business practices by the company and its officers or directors [1].
4 Top Stocks With Strong Interest Coverage for the Second Half of 2025
ZACKS· 2025-07-03 13:51
Key Takeaways HBM, STRL, MOH and VRT boast strong interest coverage ratios, signaling solid financial footing. HBM and STRL posted more than 40% EPS growth estimates, while VRT shows 24.9% growth potential. MOH projects 8.4% sales growth and 7.9% EPS growth, despite a 19.3% stock decline over the past year.Markets ended higher on Wednesday as investors weighed the latest developments in trade and the economy. Both the S&P 500 and Nasdaq Composite indices closed higher, advancing 0.47% and 0.94%, respectiv ...
Centene shares plummet as it withdraws full-year guidance
Proactiveinvestors NA· 2025-07-02 16:58
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]
These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
ZACKS· 2025-07-02 16:15
Core Insights - Corporate leadership is experiencing a significant transformation with an increase in women leading publicly traded companies, resulting in market-beating performance and innovative growth strategies [2][4] - Gender-diverse leadership is being recognized by financial markets, with ESG-focused funds prioritizing companies with women in executive roles, indicating a shift towards inclusive leadership driving sustainable growth [4] Company Highlights - **Accenture (ACN)**: Under Julie Sweet's leadership, Accenture made a $3 billion investment in AI, doubling its AI workforce and restructuring its growth model to enhance innovation and brand leadership [3] - **The Estée Lauder Companies Inc. (EL)**: Rashida La Lande's appointment as executive vice president and Global General Counsel in 2024 strengthened the company's legal and compliance frameworks during a transformation period [3] - **Adobe Inc. (ADBE)**: Lara Balazs, as chief marketing officer, has significantly enhanced Adobe's brand and marketing strategy, contributing to strong financial performance with adjusted EPS of $5.08 in Q1 2025, up from $4.48 year-over-year [9][10] - **McKesson Corporation (MCK)**: Michele Lau's role as chief legal officer has been pivotal in navigating regulatory scrutiny and managing complex litigation, with her compensation reflecting a strategic alignment with shareholder value [12][13] - **Centene Corporation (CNC)**: Sarah M. London has transformed Centene's operations since becoming CEO in March 2022, leading to $163 billion in revenues in 2024 and serving nearly 28 million members [15][16] - **Bumble Inc. (BMBL)**: Whitney Wolfe Herd's leadership has driven Bumble's brand identity and strategic shifts, including a workforce reduction aimed at achieving $40 million in annual cost savings, with improved revenue guidance for Q2 2025 [19][20] Investment Opportunities - Companies led by women, such as Adobe, McKesson, Centene, and Bumble, are positioned as attractive investment opportunities due to their strong leadership and strategic vision, indicating potential for long-term success [6]
Is Centene (CNC) Stock Undervalued Right Now?
ZACKS· 2025-07-02 14:40
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use a variety of methods, including tried-a ...
4 Stocks With Strong Interest Coverage Ratios to Buy in June 2025
ZACKS· 2025-06-03 15:45
Market Overview - U.S. stocks experienced gains on Monday, with the S&P 500 increasing by 0.41% to 5,935.94, the Nasdaq rising by 0.67% to 19,242.61, and the Dow Jones Industrial Average edging up by 35.41 points, or 0.08%, to finish at 42,305.48, despite ongoing global trade concerns [1] U.S.-China Relations - Market participants are expected to closely monitor developments in U.S.-China relations, as changes could significantly impact market sentiment [2] Importance of Financial Analysis - Investors often rely solely on sales and earnings figures, which may not accurately reflect a company's ability to meet financial obligations; thus, a critical analysis of a company's financial background is essential for informed investment decisions [3][2] Interest Coverage Ratio - The interest coverage ratio is a key metric used to assess how effectively a company can pay interest on its debt, calculated as Earnings before Interest & Taxes (EBIT) divided by Interest Expense [5][6] - A higher interest coverage ratio indicates a greater ability to meet interest obligations, while a ratio below 1 suggests potential default risks [8] Stock Recommendations - Four companies, Sterling Infrastructure, BJ's Wholesale Club, Molina Healthcare, and Halozyme Therapeutics, exhibit strong interest coverage ratios and are recommended for consideration [4][11] - These companies also demonstrate high EPS growth and favorable Zacks Ranks, indicating robust performance potential [11][14][15][16] Company Performance Highlights - Sterling Infrastructure (STRL) has a projected EPS growth of 38.5% and has risen 68.4% over the past year [14] - BJ's Wholesale Club (BJ) shows projected sales and EPS growth of 5.6% and 5.9%, respectively, with a stock increase of 29.1% in the past year [15] - Molina Healthcare (MOH) anticipates sales and EPS growth of 8.4% and 7.8%, respectively, although the stock has declined by 3.3% in the past year [16] - Halozyme Therapeutics (HALO) expects sales and EPS growth of 22.1% and 23.6%, respectively, with a stock increase of 25.6% in the past year [17]
Molina Healthcare(MOH) - 2025 Q1 - Earnings Call Transcript
2025-04-24 20:37
Molina Healthcare (MOH) Q1 2025 Earnings Call April 24, 2025 04:37 PM ET Company Participants Jeffrey Geyer - Vice PresidentJoseph Zubretsky - President & CEOMark Keim - Senior EVP, CFO & TreasurerAndrew Mok - DirectorA.J. Rice - Managing DirectorJohn Stansel - VP - Equity ResearchLance Wilkes - Managing DirectorDave Windley - Managing Director Conference Call Participants Stephen Baxter - Senior Equity Research AnalystJoshua Raskin - Research AnalystJustin Lake - Analyst - Healthcare ServicesSarah James - ...